Live Activities by Credit Type
-
Cancer Immunotherapy: An Interprofessional Approach to the Management of Immune-Mediated Adverse Events
·
TBA
·
Westwood, KS, US
·
July
11,
2018
-
Cancer Immunotherapy: An Interprofessional Approach to the Management of Immune-Mediated Adverse Events
·
TBA
·
Victoria, TX, US
·
July
11,
2018
-
Paving the Path to Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
·
JW Marriott Marquis Miami
·
Miami, FL
·
July
14,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
Stockton, CA
·
July
17,
2018
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Oxnard, CA, US
·
July
18,
2018
-
Paving The Path To Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
·
TBA
·
Titusville, FL
·
August
10,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
Medford, OR
·
September
5,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
New Hyde Park, NY
·
September
19,
2018
-
Paving The Path To Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
·
TBA
·
Philadelphia, PA
·
September
21,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
Brooklyn, NY
·
September
26,
2018
-
Paving the Path to Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
·
Penn State Milton S. Hershey Medical Center
·
Hershey, PA
·
October
5,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
Washington, DC
·
October
19,
2018
-
Paving The Path To Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
·
TBA
·
Washington, DC
·
November
9,
2018
-
Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
·
TBA
·
Salisbury, MD
·
January
11,
2019
Online Activities by Credit Type
|
The DNA damage response (DDR) pathway is an essential mechanism used to maintain genomic integrity in all cells. Nearly all cancers have deficiencies in one or two DDR pathways, resulting in increased...
Faculty
|
Activity Details
- Credit Amounts:
-
Type: Video Webcast
- Expires: Jun 3, 2019
- Cost: Free
|
|
Lung cancer is the most common cancer worldwide, as well as the leading cause of cancer death.1 Non small-cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases, and is...
Faculty
|
Activity Details
- Credit Amounts:
-
Type: Video Webcast
- Expires: Jun 19, 2018
- Cost: Free
|
|
E-mail
Begin